✦ LIBER ✦

Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy

✍ Scribed by Ralph R. Weichselbaum; John R. Clark; Daniel Miller; Marshall R. Posner; Thomas J. Ervin

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 717 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850501)55:9+<2149::aid-cncr2820551418>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy of head and neck cancer: Co

Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin

✍ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50

Multidrug chemotherapy using bleomycin,

Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer

✍ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r

Chemotherapy for head and neck cancer. C

Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate

✍ Stephen D. Williams; Enrique Velez-Garcia; Issac Essessee; Gary Ratkin; Robert B 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in

A randomized prospective comparison of m

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

✍ Steven E. Vogl; David A. Schoenfeld; Barry H. Kaplan; Harvey J. Lerner; Paul F. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 1020 KB

Combination chemotherapy with methotrexate, bleomycin, and cis-diamminedichloroplatinum (11) was compared to weekly therapy with methotrexate alone in a randomized prospective trial in 163 patients with recurrent or metastatic squamous cancer of the mucous membranes of the head and neck. The combina

Cisplatin, bleomycin, and methotrexate (

Cisplatin, bleomycin, and methotrexate (PBM) chemotherapy in locally advanced and metastatic head and neck cancer

✍ Dr. B. Uziely; T. Peretz; A. Sulkes; E. Feigin; R. Isacson; S. Biran 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

✍ Marcel Rozencweig; Pierre Dodion; Uta Bruntsch; Walter Gallmeier; Michel Clavel; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

A combination of cisplatin, methotrexate, bleomycin, and vincristine (CABO) was assessed in advanced epidermoid head and neck cancer. Among 72 patients with recurrent or metastatic disease and measurable lesions, there were 9 complete and 27 partial responses for an overall response rate of 50%. The